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2 
Abstract 25 
 26 
Background: Vitamin D deficiency (VDD) affects the health and wellbeing of millions 27 
worldwide. In high latitude countries such as the United Kigdom (UK), severe complications 28 
disproportionally affect ethnic minority groups.  29 
Objective: To develop a decision-analytic model to estimate the cost-effectiveness of 30 
population strategies to prevent VDD. 31 
Methods: An individual-level simulation model was used to compare: (I) wheat flour 32 
fortification; (II) supplementation of at-risk groups; and (III) combined flour fortification and 33 
supplementation; with (IV) a ‘no additional intervention’ scenario, reflecting the current 34 
Vitamin D policy in the UK. We simulated the whole population over 90 years. Data from 35 
national nutrition surveys were used to estimate the risk of deficiency under the alternative 36 
scenarios. Costs incurred by the health care sector, the government, local authorities, and the 37 
general public were considered. Results were expressed as total cost and effect of each strategy, 38 
and as the cost per ‘prevented case of VDD’ and the ‘cost per Quality Adjusted Life Year 39 
(QALY)’.  40 
Results: Wheat flour fortification was cost-saving as its costs were more than offset by the cost-41 
savings from preventing VDD. The combination of supplementation and fortification was cost-42 
effective (£9.5 per QALY gained). The model estimated that wheat flour fortification alone 43 
would result in 25% fewer cases of VDD, while the combined strategy would reduce the number 44 
of cases by a further 8%. 45 
Conclusion: There is a strong economic case for fortifying wheat flour with Vitamin D, alone 46 
or in combination with targeted vitamin D3 supplementation. 47 
  48 
  
 
 
3 
Introduction 49 
Vitamin D helps to maintain adequate levels of calcium and phosphorus in the body, playing a 50 
fundamental role in bone and muscle health (1). The main source of Vitamin D is sunlight 51 
exposure and many behavioural, cultural or environmental factors increase the risk of VDD 52 
by limiting the skin’s direct exposure to sunlight. Risk factors for VDD include, for example, 53 
sun screen use, air pollution, indoors lifestyles, full body clothing, and living in high latitude 54 
settings (2,3). People with dark pigmented skin who live in setting with limited sunlight, such 55 
as high latitude countries are also at a higher risk for VDD, as well as older adults, 56 
particularly if institutionalised. VDD can lead to poor health and its symptoms manifest as 57 
osteomalacia, bone pain, muscle weakness and consequent increased risk of falls. In children, 58 
severe VDD additionally causes hypocalcaemia (low levels of calcium in the blood), which is 59 
associated with seizures, tetany and heart failure (4,5), and rickets with osteomalacic leg 60 
bowing, muscle weakness and delayed infant development. Morbidity from VDD is 61 
predominantly found in individuals from Black and Asian Minority Ethnic (BAME) groups 62 
living in high-latitude countries, including in the UK (6,7), the US (8), Canada (9), 63 
Scandinavian countries (10–13) and Australia (8,14). Nonetheless, VDD is common in many 64 
populations across the world, regardless of ethnicity.  65 
In response, most countries have adopted policies to increase the populations’ intake of 66 
vitamin D, which generally consist of a combination of supplementation and food fortification 67 
strategies (15). In the UK, multivitamin supplements containing vitamin D are recommended 68 
to all infants and children up to the age of four, as well as to pregnant women and 69 
breastfeeding mothers (16). These vitamins are provided free-of-charge to those in low-70 
income households. In addition, infant formulas and spreadable fats are mandatorily fortified, 71 
while other foods including breakfast cereals and milk substitutes are voluntarily fortified. 72 
While both supplements and fortified foods are important sources of vitamin D for the UK 73 
  
 
 
4 
population, evidence suggests supplementation polices are not working (7,17) and the mean 74 
daily vitamin D intake is still below the Reference Nutritional Intake (RNI) of 400 IU per day 75 
(2,18). Therefore, rickets and hypocalcemic complications remain a serious health issue and 76 
cause of death in infants, particularly in the BAME group (4,7,19,20). Evidence shows that 77 
vitamin D status, which is measured through the blood concentration of a Vitamin D 78 
metabolite, the 25-hydroxyvitamin D [25(OH)D], is suboptimal in 13% of the European 79 
population (21). In the UK population, 20% of adults and 16% of children aged between 11 80 
and 18 years are estimated to be VDD (2), with the BAME group being, by far, the most 81 
affected (10,12,22–25). 82 
So far, the economic evidence needed to inform and underpin VDD prevention policies has 83 
been limited (26). To the best of the authors’ knowledge’, there is no evidence on the cost-84 
effectiveness of preventing population VDD through food fortification or a combination of 85 
food fortification and supplementation, even though the latter is the approach taken in most 86 
countries (15). This study estimates the cost-effectiveness of preventing VDD using the 87 
population of England and Wales as a simulated cohort and compares the strategies of 88 
supplementation of at-risk groups, wheat flour fortification, and a combination of the two 89 
approaches. 90 
 91 
Methods  92 
An individual-level state-transition model was developed to compare four different strategies 93 
to prevent population VDD.  A state transition model was chosen to allow recurrence of VDD 94 
over the life course, and individual-level simulation was used to make the most efficient use 95 
of available data on risk heterogeneity for VDD in the population, as well as to account for 96 
individual pathways across the model’s time horizon (27,28). The model used a one-year 97 
cycle length, and both costs and benefits were discounted at 3.5% per year, as recommended 98 
  
 
 
5 
by the UK National Institute for Health and Care Excellence (NICE) (29). The base case 99 
analysis was done from a societal perspective and results reported using incremental cost 100 
effectiveness ratios (ICER) in the form of cost per additional quality-adjusted life year 101 
(QALY) gained, and cost per prevented case of VDD.  The model was built in TreeAge Pro 102 
2016 software, and followed modelling (28,30) and reporting (31) guidelines for good 103 
practice.   104 
The model comprised three main health states (Figure 1). These health states were mutually 105 
exclusive and represent clinically relevant stages: 106 
1) Vitamin D deficient (VDD): all children with serum 25(OH)D concentrations below 107 
30nmol/L (3) and adults with serum 25(OH)D below 50 nmol/L (32).  108 
2) Vitamin D sufficient (VDS): all children with serum 25(OH)D concentrations above 109 
30nmol/L (3) and adults with serum 25(OH)D above 50 nmol/L (32). 110 
3) Dead: based on all-cause mortality and naturally treated as an absorbing state.  111 
 112 
[Figure 1] 113 
 114 
The majority of the VDD population were assumed to be asymptomatic. Within the model, 115 
asymptomatic individuals followed a pathway with the possibility of remaining deficient or 116 
becoming sufficient over time. For the deficient population who become symptomatic, 117 
children were assigned a risk of developing rickets and hypocalcemic complications, and 118 
adults a risk of developing osteomalacia. Younger adults aged between 19-64 years old who 119 
acquire osteomalacia suffer from diffuse pain and muscle weakness. Older adults with 120 
osteomalacia had a modest increased risk of falls due to pain and muscle weakness. The full 121 
model structure depicting the clinical pathways for children and adults with symptomatic 122 
VDD can be found in the supplementary material (Figure S1 and Figure S2). 123 
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The starting cohort within the model was simulated based on the population of England and 124 
Wales, according to its age, sex and ethnicity distributions (33). The following four 125 
alternative strategies were compared: (I) wheat flour fortification at 400IU of Vitamin D per 126 
100 g of wheat flour; (II) free supplementation to all at-risk groups; (III) a combination of 127 
flour fortification and supplementation; and (IV) no additional intervention, i.e. maintaining 128 
the current fortification and supplementation policy of providing supplements to young 129 
children, pregnant women and breastfeeding mothers within low-income households, and 130 
fortifying certain food groups. Wheat flour was chosen as the most appropriate food for 131 
fortification since, contrary to milk and spreadable fats, flour is a staple food across multiple 132 
ethnic groups, including Asian, African, Caribbean, and white ethnic groups, and therefore 133 
will potentially reach multiple at-risk groups. Evidence from Scandinavian countries shows 134 
that milk supplementation is not as effective in reaching ethnic minority groups as it is in 135 
reaching white ethnic groups (15). Regarding safety, a UK study that compared vitamin D 136 
fortification of milk, flour and a combination of both showed that flour fortification alone 137 
presented the lowest risk of toxicity in the population (34). Wheat flour is already fortified in 138 
the UK, and addition of vitamin D to the mix of added nutrients is likely to carry lower 139 
implementation barriers than targeting an industry that has no fortification infrastructure, in 140 
place, such as milk in the UK.  The baseline risk of VDD was estimated using individual-level 141 
intake data reported from the National Diet and Nutrition Survey (NDNS) (18,35). The intake 142 
of vitamin D included all food sources (natural and fortified foods, including voluntarily 143 
fortified). Differences in intake by age group and sex were considered. 144 
The effectiveness of wheat flour fortification in reducing the risk of being VDD by sex was 145 
derived from Allen et al.’s nutrition model (34,36). Ethnicity specific effects were not 146 
available and therefore the same effect was assumed for white and BAME populations. The 147 
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full list of the transition probabilities used in the model for the current UK policy and wheat 148 
flour fortification is presented in the supplementary material (Table S1.A. and Table S1.B.). 149 
The effect of the supplementation programme was based on data provided by a local 150 
government organization in London, UK (37), which recorded the uptake of free vitamin D 151 
supplements using an electronic card system. In this Local Authority, all children up to 4 152 
years old, pregnant women and breastfeeding mothers were eligible to receive free Vitamin D 153 
supplements. In our model, supplements were provided to all sub-populations at risk of 154 
symptomatic VDD including all infants and young children up to 18 years old; individuals of 155 
all ages from BAME backgrounds; and all individuals aged over 65 years. In the absence of 156 
data on the uptake of supplements by adults and older children (>4 years old), we assumed the 157 
same uptakes in older and younger children to that of children <4 years, and the adult uptake 158 
to be the same as that of pregnant and breastfeeding women. The model assumed a 159 
supplement dosage of 400IU per day for all groups except for the elderly, who received 160 
800IU per day as per the recommended minimum dose to prevent falls (38). The effectiveness 161 
of the combined scenario (wheat flour fortification plus supplementation of at-risk groups) 162 
was estimated as the additive effectiveness of each strategy alone.  163 
Outcomes 164 
Preventing VDD in the population reduces the risk of poor bone and muscle health. The 165 
outcome unit used for the cost-effectiveness analysis was the number of cases of VDD 166 
prevented. For the cost-utility analysis, the health-related quality of life (HRQoL) for a given 167 
health state was combined with the time spent in that health state to formulate QALYs. The 168 
preference-based quality of life values (i.e. utilities) applied to estimate QALYs were sourced 169 
from two HRQoL studies, published elsewhere (39), one focusing on VDD in children, and 170 
the other in adults (supplementary material, table S2).  171 
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 172 
Costs 173 
Cost data were derived from multiple sources (supplementary material, table S3). For the 174 
wheat flour fortification strategy, the price of dried vitamin D was obtained from a UK 175 
commercial flour supplier of the food industry (LFI (UK) Ltd). The costs of re-labelling 176 
packages, used in a sensitivity analysis, and the public sector costs of enforcing mandatory 177 
fortification were sourced from the Food Standards Agency‘s study of wheat flour 178 
fortification with folic acid (40). The cost structure of the supplementation programme was 179 
based on the Local Authority’s supplementation programme (37), which was pharmacy-led. It 180 
was assumed that supplements would be supplied through community pharmacies, which 181 
would receive an initial financial incentive for participating in the programme and 182 
reimbursements for the cost of the supplements dispensed. An additional incentive would be 183 
provided for each supplement dispensed to encourage sustained adherence to the programme.  184 
Uncertainty and sensitivity analyses 185 
Several sensitivity analyses were conducted to determine how sensitive the model results 186 
were to the assumptions made (Table 1). First, the time horizon was varied to 5 and 10 years. 187 
Second, the discount rate for both costs and benefits was set to 1.5%. Third, the perspective 188 
was altered to include only public sector costs, therefore eliminating all private costs borne by 189 
the food industry. Fourth, following the Food Stardards Agency report on the cost of 190 
fortifying flour with folic acid in the UK (40), the model included a conservative estimate for 191 
the food industry costs of relabelling flour packages, and all products containing flour, such as 192 
cakes and biscuits. Fifth, the model assumed no disutility from asymptomatic VDD. Sixth, the 193 
starting cohort was altered to include a higher proportion of BAME individuals, reflecting the 194 
population mix of many large UK cities (33). Finally, a probabilistic sensitivity analysis was 195 
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conducted based on 10,000 iterations of a Monte Carlo simulation, using the model parameter 196 
distributions listed in the supplementary material (Tables S4-S11). 197 
 198 
[Table 1] 199 
 200 
Results 201 
The model base case analysis showed that wheat flour fortification was cost-saving, which 202 
means that it led to fewer costs and more benefits when compared to the current national policy 203 
in England and Wales, and is therefore described as dominant (Table 2). All other strategies 204 
were found to be superior to the current national policy in terms of cases of VDD prevented.  205 
The model estimated that if the current VDD policy is kept in place, there will be almost 40 206 
million new cases of VDD – asymptomatic and symptomatic - over the next 90 years. 207 
Introducing wheat flour fortification would result in a 25% reduction in this number, and if that 208 
is combined with an additional supplementation programme then a further 8% would be 209 
prevented (33% in total). The model estimated that wheat flour fortification would lead to an 210 
increased expenditure of £0.12 per person per year based on consumption estimates that include 211 
common flour based products such as cakes and biscuits (41). The model found the strategy of 212 
flour fortification to be cost-saving, saving approximately £65 million over a 90-year time 213 
horizon. If food fortification is combined with supplementation, then this would lead to an 214 
additional cost of nearly £2 per case of VDD prevented but more cases of VDD would be 215 
prevented when compared to fortification alone. 216 
 217 
[Table 2] 218 
 219 
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The analysis showed that wheat flour fortification at 400IU per 100g of flour combined with 220 
targeted supplementation at 400IU for children up to 18 years old and all individuals from 221 
BAME backgrounds and 800IU for all individuals older than 65 years old is cost-effective. The 222 
intervention costs on average £0·38 per person across the whole population (total costs over the 223 
90 years modelled is 250 million) and leads to an average gain of 0·04 QALYs, resulting in an 224 
ICER of £9·50 per QALY gained (table 3). Under commonly applied UK thresholds of 225 
willingness to pay per QALY, this represents a highly cost-effective use of resources.  226 
[Table 3] 227 
 228 
The sensitivity analyses showed the model results were not sensitive to the majority of the 229 
assumptions made. Consistently, with each subsequent sensitivity analysis, the model showed 230 
the flour fortification strategy to be dominant and the combined strategy to impose a small cost 231 
but to be highly cost-effective. Evidence from the literature suggests that asymptomatic VDD 232 
– (serum concentrations of 25(OH)D levels below the deficiency threshold, but no overt 233 
symptoms), if coexisting with limited dietary calcium, are regarded as a pre-clinical health risk 234 
state, with diffuse pain (1), muscle weakness and fatigue (42), and thus likely to impact on 235 
quality of life. In the base case analysis, a detrimental impact on HRQoL was assumed based 236 
on an expert elicitation study (39). We tested this assumption in a sensitivity analysis and noted 237 
that when it is assumed that the asymptomatic VDD health state results in the same quality of 238 
life as being vitamin D sufficient, then the combined strategy has no additional benefit 239 
(supplementation material, appendix 4). 240 
Finally, the probabilistic sensitivity analysis (Figure 2) showed that for willingness to pay 241 
values of up to £200 per QALY, wheat flour fortification is the recommended option. For values 242 
above £200 per QALY, a combination of wheat flour fortification and supplementation of all-243 
at risk groups is the optimal strategy.  244 
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 245 
[Figure 2] 246 
 247 
 248 
Discussion 249 
Our model found that implementing strategies to prevent VDD is likely to be cost-effective and 250 
wheat flour fortification to be cost-saving as compared to the current policy in England and 251 
Wales. The costs of implementing and running the fortification scheme were more than 252 
compensated for by the health care savings from preventing more cases of VDD. Alternatively, 253 
the combined strategy of adding Vitamin D to wheat flour and extending the coverage of 254 
supplementation to all at-risk groups would be highly cost-effective strategy. Therefore, for an 255 
additional cost, the combined strategy prevents more cases of VDD when compared to 256 
fortification alone and under conventional decision-making rules(43), this additional cost would 257 
be regarded as a highly cost-effective use of public resources. 258 
 259 
These results of our study are in line with published economic evaluations of food fortification 260 
programmes for other micronutrients, such as folic acid (44–46), which have found food 261 
fortification to be cost-saving, in pre- and post-implementation studies. The economic 262 
advantage of food fortification lies in the wide-coverage and shared costs across the private 263 
sector, consumers and the government. Food fortification has the potential to target hard-to-264 
reach populations, overcoming some of the problems with low uptake of supplementation 265 
programmes. Moreover, fortification has a far lower burden on the health care budget than 266 
supplementation alternatives, as most costs of the food fortification programme are borne by 267 
the food industry, and passed on to the consumer. However, a combined strategy offers both a 268 
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nutritional safety net to the population by fortifying the food chain, and a targeted 269 
supplementation scheme to those who are most in need. 270 
 271 
We have included children, BAME groups and individuals aged over 65 years old in the at-risk 272 
group of the population. Even though most severe cases of VDD have been reported in BAME 273 
mothers and their new-borns, overall pregnant women benefit from adequate levels of 25OHD.  274 
Most vitamin D supplementation policies around the world already target pregnant women and 275 
infants. When considering new public health approaches to reach at-risk and vulnerable groups, 276 
pregnant women should continue to be a target group for the strategy of supplementation. 277 
 278 
The analysis presented here is based on hypothetical scenarios with conservative assumptions 279 
applied to increase confidence in the results. For example, potential savings in primary care 280 
associated with consultation of general practitioners and testing were not included, such as the 281 
economic burden from routine 25(OH)D testing. In children alone, these costs were estimated 282 
to be £1·7 million (at 2014 prices) (47). As new and more expensive diagnostic tests are 283 
introduced, the economic burden is likely to increase. Furthermore, conservative estimates 284 
regarding the modelling of VDD-related falls in the elderly were also applied, based on a recent 285 
economic evaluation study by Poole et al (2015) (48).  286 
 287 
We have focused on the benefits of vitamin D to bone and muscle health. The emerging 288 
evidence of potential wider benefits of maintaining a healthy vitamin D status such as 289 
prevention of cancer and cardiovascular disease (49,50), acute respiratory infections, (51) and 290 
other illnesses (52),  suggests that the impact of public health measures to tackle vitamin D 291 
deficiency might be even stronger than that reported in this study. A recent meta-analysis using 292 
individual patient data from over 10,000 individuals found that vitamin D supplements reduced 293 
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the risk of acute respiratory infections, such as colds and the flu, which have a tremendous 294 
burden in population health and health systems (51). As more robust evidence on non-295 
musculoskeletal effects of vitamin D from interventional studies become available, there is 296 
potential for future models to incorporate these additional benefits. If the same public health 297 
measures compared in our model are able to prevent other diseases, the cost-effectiveness 298 
results will be even more favourable that the ones we present here. 299 
One of the strengths of the model is that it was informed by direct communication with 300 
stakeholders, including clinical experts, local UK public health organisations, established 301 
researchers with experience in economic evaluation of micronutrient interventions, and expert 302 
investigators in the economics of food fortification. Moreover, this is the first model to compare 303 
supplementation and food fortification with vitamin D independently, as well as the 304 
combination of both in the same analysis, which is a more meaningful way of representing the 305 
relevant alternatives for policy makers to consider. Our findings were robust when tested under 306 
a number of deterministic sensitivity analyses and a probabilistic sensitivity analysis. 307 
 308 
The model has some limitations. Data on the costs and uptake of the supplementation 309 
programme were sourced from a Local Authority, and were extrapolated to a nation-wide 310 
scenario. Regarding the costs, for example, purchases at the national level might achieve 311 
economies of scale and result in lower costs. To account for this uncertainty, each relevant 312 
model input (eg. cost estimates) was assigned a wide distribution within the probabilistic 313 
sensitivity analysis. There was a lack of data on the uptake of supplements by ethnic groups 314 
who have different risk profiles for developing VDD. In the absence of uptake data by ethnic 315 
group, equivalent levels were applied to all ethnic groups. Furthermore, the cost and 316 
effectiveness of the combined strategy was assumed to be the sum of the costs and effectiveness 317 
of the flour fortification and supplementation strategies combined. In reality, if implemented 318 
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simultaneously, interactions between the two strategies are likely, although it is unknown in 319 
which direction. Finally, the model only included the health-related benefits from preventing 320 
VDD and any other benefits beyond health were not included. Economic evaluation requires 321 
that the relevant benefits and costs of each of the policy alternatives are quantifiable. This is the 322 
greatest challenge when applying standard economic evaluation methods to the prevention of 323 
micronutrient deficiencies. The benefits from reducing the prevalence of vitamin and mineral 324 
deficiencies are wide but hard to measure (53). Nutrition, including vitamin D status, impacts 325 
human development from conception until the later stages of life (54–56). Moreover, poor 326 
nutrition affects socioeconomically disadvantaged groups of the population, and tackling it 327 
would have a wider economic benefit by addressing health and social inequalities (57). For 328 
example, there would be a clear social benefit from reducing the prevalence of VDD in minority 329 
ethnic groups, as it would reduce any stigma associated with rickets in children (58). 330 
 331 
The effectiveness of any fortification programme depends on a number of programme design 332 
choices, for example, the food chosen needs to be consumed by the targeted population, and 333 
the price increase of the final product should be kept low, so that no access barriers based on 334 
income are not created (53,59). These features of a programme are particularly important in the 335 
context of VDD since BAME groups are at a higher risk. Other studies have highlighted that 336 
there is a need to collect data on the diet and nutritional status of BAME populations in the UK 337 
(60). We corroborate such needs. To date, nutritional data from the NDNS have not been 338 
reported by ethnic group. Doing so would facilitate implementation of food fortification 339 
programmes, the effectiveness of which could be monitored using the existing structures, as 340 
done in other countries such as Finland (21). Fortifying flour would ensure that population 341 
serum 25(OH)D concentrations are raised to safe levels with supplementation used to target 342 
subgroups that the fortification programme may not reach effectively.  343 
  
 
 
15 
 344 
VDD is wide-spread in the population, it has a negative impact on HRQoL with a burden of 345 
disease that is much larger than rickets and osteomalacia. VDD and its complications are 346 
preventable and well-planned public health strategies can be highly cost-effective and even 347 
cost-saving. Biological, environmental, cultural, historical, and economic factors influence how 348 
VDD affects the population, as well as the cost and effectiveness of alternative strategies. 349 
Therefore, tackling population VDD in England and Wales requires efforts from 350 
multidisciplinary professionals, such as clinicians, nutritionists, health economists, public 351 
health professionals, and policy makers.  352 
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Figures legends 
Figure 1 – Illustration of the model structure 
Figure 2 – Cost-effectiveness acceptability curve (CEAC) showing the probability of 
alternatives to prevent VDD being cost-effective at increasing acceptability thresholds  
 
